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Background: Anemia is a common problem in diabetic patients. Diabetic patients have a greater severity of
anemia as the level of Glomerular Filtration Rate (GFR) decreases compared to non-diabetic patients. Despite these
facts, anemia is unrecognized and largely untreated in patients with diabetes in Ethiopia particularly in those
patients attending Fenote Selam Hospital. Therefore, this study was aimed to assess the association of anemia and
renal function test among diabetes mellitus patients attending Fenote Selam Hospital, North West of Ethiopia.
Methods: An Institutional -based cross-sectional study was conducted from February 2012 to April 2012 on
diabetes mellitus (DM) patients. Systematic random sampling technique was used to get the total sample size of
384 patients. A total of seven ml of venous blood was collected from diabetes mellitus patients; two ml was
collected by EDTA anticoagualted vacutainer test tube for haemoglobin determination and 5 ml venous blood was
collected by plain vacutainer tube for creatinine and Blood urea nitrogen determination. The data were double
entered and analyzed using SPSS-16 statistical software. The degree of association between independent and
dependent variables was assessed using bivariate and multivariate logistic regression analysis in terms of P-value
and odds ratio with 95% confidence interval.
Results: Out of the total 384 DM patients included in the study 73 (19%) were anemic. Fifty three (13.8%), forty
eight (12.5%), and two hundred eighty three (73.7%) DM patients had an estimated GFR <60 ml/min/1.73 m,
60 – 90 ml/min/ 1.73 m, and > 90 ml/min/1.73 m respectively. One hundred eleven (28.9%) diabetic patients had
increased urine albumin level. There was a statistically significant association between anaemia and Glomerular
filtration rate (P<0.05) with Odds ratio of 8.58 and CI (10.21, 49.94). As the glomerular filtration rate increase, the risk
to be anemic will decrease dramatically.
Conclusion: The study showed that there was a significant association between anaemia and Glomerular filtration
rate in DM patients. Therefore, DM patients should be strictly monitored for renal failure and anemia for proper
management of diabetes patients.Background
Anemia is defined by World Health Organization (WHO)
criteria: < 13 g ⁄ dl for men and < 12 g ⁄dl for women [1].
The etiology of anemia in diabetes is multifactorial and
includes inflammation, nutritional deficiencies, concomi-
tant autoimmune diseases, drugs, and hormonal changes* Correspondence: yeshmebetessey@gmail.com
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reproduction in any medium, provided the orin addition to kidney disease. Anemia that is associated
with erythropoietin deficiency may have prognostic signifi-
cance for persons with nephropathy [2].
Anemia is associated with an increased risk of the
vascular complications of diabetes including nephropathy,
retinopathy, neuropathy, impaired wound healing, and
macrovascular disease [3]. The strong link between the
kidney and anemia in diabetes probably reflect the unique
vulnerability of the renal microcirculation to damage intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is present before albumin is found in the urine.
Anemia occurs earlier, and is more severe, in chronic
kidney disease (CKD) related to diabetes than in non-
diabetic CKD [5]. Patients presenting with diabetic ne-
phropathy commonly have a greater degree of anemia for
their degree of renal impairment than those presenting
with other causes of renal failure, and anemia develops
earlier in these patients than in those with renal impair-
ment from other causes [6].
A number of studies have reported the prevalence of
anemia in people with diabetes and have suggested that
up to 25% have previously unrecognized anemia [6,7].
Recent studies have identified anemia as a risk factor for
the need for renal replacement therapy in diabetes; in
addition, a lower HGB is significantly associated with a
more rapid decline in the glomerular filtration rate (GFR).
Furthermore, treating anemia early in renal failure has
been demonstrated to slow the rate of decline of renal
function [8].
Increasing evidence suggests that anemia in the diabetic
population, whether type 1 or type 2, is a potent and inde-
pendent predictor of increased risk for macrovascular and
microvascular complications of diabetes. Despite these
facts, anemia is unrecognized and largely untreated in
patients with diabetes in Ethiopia particularly for popula-
tions in the study area. Therefore, the result of this study
was aimed to identify the association of anemia and renal
function test among DM patients attending Fenote Selam
Hospital.Methods
Study design and area
An Institutional-based cross-sectional study was con-
ducted at Fenote Selam hospital from February 2012 to
April 2012. The hospital consists of an operating room,
one intensive care unit (ICUs) with 12 beds, 6 wards
with 130 beds and an outpatient department. The study
population was all DM patients who visit Fenote Selam
Hospital, diabetes clinic during data collection time. Dia-
betic patients who have got anemia correction treatment
like iron and transfusion therapy in the last three
months of data collection were excluded from the study.
Ethiopia is a country located in the Horn of Africa. It
is bordered by Eritrea to the north, Djibouti and Somalia
to the east, Sudan and South Sudan to the west, and
Kenya to the south. With over 91,000,000 inhabitants,
Ethiopia is the most populous landlocked country in the
world and the second-most populated nation on the
African continent. It occupies a total area of 1,100,000
square kilometers (420,000 sq mi), and its capital and
largest city is Addis Ababa.
Finote Selam is a town and separate woreda in western
Ethiopia. Located in the Mirab Gojjam Zone of the
Amhara Region, this town has a longitude and latitude of
10°42’N 37°16’E/10.7°N 37.267°E Coordinates: 10°42’N 37°
16’E/10.7°N 37.267°E with an elevation of 1917 meters
above sea level. In 1964, a hospital for lepers had been
built in Finote Selam by the private fund “Swedish Aid to
Leprous Children in Ethiopia”. The hospital is one of the
zonal (large) hospital found in the Amhara region.
Abate et al. BMC Hematology 2013, 13:6 Page 3 of 7
http://biomedcentral.com/2052-1839/13/6Source population
The source population was all DM patients attending
Fenote selam Hospital and the study population was all
DM patients who visit Fenote Selam Hospital, diabetes
clinic during data collection time. Out of which The DM
patients who visit Fenote selam Hospital, diabetes clinic
and become were our study participant.
Sample size and sampling techniques
A total of 384 study participants were determined by
single population proportion sample size calculation
formula with study population size less than 10,000 (9).
Systematic random sampling was used to select study
participants. Every other study participants were selected
after a random starting study participant who was se-
lected by lottery method.
Sample collection and examination
Socio demographic data were collected by using a struc-
tured questionnaire first prepared in English language
and translated in to a local language Amharic and again
translated to English. Two (2) ml venous blood was
collected by vacutainer test tube coated EDTA anti-
coagulant for haemoglobin determination. The collected
whole blood was mixed properly and analyzed for
hemoglobin determination using CELL DYNE 1800
hematology analyzer. Five (5) ml venous blood was col-
lected by vacutainer test tube without any anticoagulant
for creatinine and Blood Urea Nitrogen determination.
The whole blood without anticoagulant was allowed to
clot for 15 to 30 minutes and was then centrifuged at
3000 rpm for 5 min and serum was separated. The sepa-
rated serum was used to determine Creatinine and
Blood Urea Nitrogen (BUN) using Humastar 80 chem-
istry analyzer.
Data analysis
All the data were manually checked for its clarity and
completeness and then coded and entered into Epi-info
and transported to SPSS version 16.0 soft ware package
for analysis. For controlling errors frequency checks was
done. The data was analyzed for its descriptive statistics
and bivariate logistic regression to determine the effect
of various factors on the outcome variable and multi-
variate logistic regression to control confounding effect.
The result was presented in the form of tables, figures
and text using frequencies and summary statistics such
as mean, standard deviation and percentage to describe
the study population in relation to relevant variables.
P-value less than 0.05 was taken as statistical significant.
The degree of association between independent and
dependent variables was assessed using odds ratio with
95% confidence interval of Bivariate and Multivariate
logistic regression.Quality assurance
Quality assurance checks were performed daily according
to the laboratory’s protocol. Commercial control materials
was properly warmed and mixed according to the manu-
facturer’s recommendations. Internal quality control was
conducted: after daily start up procedures are completed,
when reagent lot changed, and when there is a reason to
suspect an error in the data or results. Results was
recorded, dated and initialed on the appropriate forms.
Lot numbers, reagents, and expiration date are recorded
where applicable.Ethical consideration
The study was reviewed and approved by the ethical
committee of the School of Biomedical and Laboratory
Sciences. Permission to conduct the study was also
obtained from the Fenote selam hospital. Informed
consent was obtained after each study participants was
informed about the objective of the study and then any
participant who is not willing to participate in the study
was not forced to participate. They were also informed
that all data obtained from them would be kept confi-
dential by using codes instead of any personal identifiers
and is meant only for the purpose of the study. Physi-
cians were informed about Anemic and renal damaged
patients for proper management.Results
Socio-demographic characteristics of the diabetes
mellitus patients
A total of 384 DM patients were involved in this study,
of which 61.5% of the respondents were males and
38.5% were females. The mean age of participants was
40.96 with 16.8SD. Of the participants 226 (58.9%) were
married, 66 (17.2%) were government employees and
347 (90.4%) were the followers of orthodox Christianity
and 123 (32.0%) were unable to read and write. From
the total DM patients, 166 (43.2%) were rural residents
and 218 (56.8%) were urban residents (Table 1).Anemia and clinical characteristics of diabetes mellitus
patients
The distribution of type one and type two DM was 193
(50.3%) and 191 (49.7%) respectively. The duration of DM
with these patients ranges from one year to thirty years
with the mean year of 5.87 and SD. 4.7 years. Seventy
three (19.0%) of these DM patients was anemic (below
13 mg/dl for men and 12 mg/dl for women). Of these 38
(52.1%) and 35 (47.9%) were male and female respectively.
Sixteen 16 (21.9%) and 57 (78.1%) of anemic DM patients
were type one and type two respectively (Table 2).
Table 1 Socio-demographic characteristics of DM patients
attending fenote Selam Hospital, West Gojam, Northwest
Ethiopia, 2012
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Urine Albumin, Serum Creatinine, Serum BUN, and
Glomerular Filtration Rate (GFR) were determined for DM
patients to determine the function of the kidney. Two hun-
dred seventy three (71.1%) had a normal urine albumin
where as 111 (28.9%) had increased urine albumin level.
The mean estimated GFR was 112.12 ml / min/1.73 m2.
Fifty three (13.8%), forty eight (12.5%), and two hundred
eighty three (73.7%) of DM patients had an estimated GFR
<60 ml/min/ 1.73 m, 60 – 90 ml/min/ 1.73 m, and > 90 ml/







Able to read & write 41 10.7
Primary educ. (1–8) 123 32.0
Secondary (9–10) 39 10.2
Preparatory(11–12) 32 8.3





Widowed 46 12.0Bivariate risk factor analysis for anemia among diabetes
mellitus patients
During bivariate analysis of variables, factors found to be
significantly associated with anemia were: Age of the
patients, Residence, Type of DM, Duration with Diabetes
Mellitus, Type of treatment, Co-existing diseases, Fasting
blood sugar (FBS), Mean cell volume, Urine Albumin,
Serum Creatinine, Serum blood urea nitrogen (BUN), and
Glomerular filtration rate (Table 4). Diabetes mellitus
patients with an eGFR below 60 ml/min/ 1.73 m2 and
between 60–89 ml/min/ 1.73 m2 have 11 times greater
(AOR11.13, 95% CI =2.69, 45.94) and (AOR4.29 95% CI =
1.14, 16.13) risk to be anemic than DM patients with an
eGFR above 90 ml/min/ 1.73 m2 respectively. Diabetes
mellitus patients who have Type two DM have 4 times
(COR = 4.71, 95% CI = 2.58, 8.55) greater risk to be than










Others 37 9.6Multivariate analysis of different variables relation to
anemia among diabetes mellitus
All socio-demographic and other variables that showed
significant associations and P-value < 0.2 with anemia in
bivariate analysis were selected and entered for multi-
variate logistic regression analysis to identify the most
important predictors of anemia. From the variables
found to be significant in the bivariate analysis only
Type of DM, Duration with DM, Mean cell volume,
Glomerular filtration rate, Serum Creatinine, and marital
status were found to be significantly associated with
anaemia in multiple logistic regression analysis using
P-value, odds ratio, and confidence interval. Diabetes
mellitus patients with a glomerular filtration rate be-
tween 60–90 ml/min/ 1.73 m have a 4 times greater
(AOR = 4.29, 95% CI = 1.14, 16.13) risk to be anemic
than DM patients with a normal Glomerular Filtration
Rate. Diabetes mellitus patients with a moderate renal fail-
ure had an 11times greater risk (AOR = 11.13, 95% CI =
2.69, 45.94) to be anemic than a normal renal function
(Table 5).Discussion
Among 384 DM patients, 61.5% of the respondents were
males and 38.5% were females, 50.3% were type one and
49.7% were type two DM. The current study showed
that the overall prevalence of anemia in DM patients
was 19%. This prevalence is in agreement with the stud-
ies done in other countries [9-11]. This over representa-
tion of males might be due to: the prevalence of DM is
higher in males than females in the study area, mostly
females prefer to go to Traditional healers to use
Table 3 Renal function test results among diabetes
mellitus patients attending fenote Selam Hospital, West
Gojam, Northwest Ethiopia, 2012










Glomerular filtration rate (GFR)
<60 ml/min/1.73 m 53 13.8
60 – 90 ml/min/1.73 m 48 12.5
>90 ml/min/1.73 m 283 73.7
Table 2 Anemia and clinical characteristics of diabetes
mellitus patients attending fenote Selam Hospital, West
Gojam, Northwest Ethiopia, 2012
Anemia
Variables (N = 384) Frequency (%) Yes (%) No (%)
Type of diabetes mellitus
Type 1 193 (50.3) 16 (4.2) 177 (46.1)
Type 2 191 (49.7) 57 (14.8) 134 (34.9)
Duration with diabetes
mellitus
<5 yrs 206 (53.6) 7 (1.8) 199 (51.8)
6-10 124 (32.6) 30 (7.8) 94 (24.5)
>11 54 (14.1) 36 (9.4) 18 (4.7)
Type of treatment
Lente insulin 224 (58.3) 23 (6.0) 201(52.3)
Metformin 160 (41.7) 50 (13.0) 110 (28.6)
Co-existing diseases
No 316 (82.3) 47 (12.2) 269 (70.1)
Yes 68 (17.7) 26 (6.8) 42 (10.9)
Fasting blood sugar
<126 105 (27.3) 7 (1.8) 98 (25.5)
>126 279 (72.7) 66 (17.2) 213 (55.5)
MCV
Normal 274 (71.4) 13 (3.4) 201 (68.0)
Decreased 110 (28.6) 60 (15.6) 50 (13.0)
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health facilities and Most females were excluded due to
iron therapy for anemia correction.
This study revealed that anemia is significant in Type
two DM with AOR of 4.17 (95% CI = 2.58, 8.56) and
anemia is also associated with duration of Diabetes
Mellitus for greater than eleven years are seven times
(AOR 7.47, 95% CI 1.51, 37.07) more likely to develop
anemia than patients with DM for less than five years.
This result is in agreement with other studies [12,13].
This study also showed that the prevalence of anaemia
increases with older ages (27.4%) of DM patients whose
age is greater than 60 years are anemic. This result is in
agreement with a study in Israel, which indicates age has
a significant association with anaemia in DM patients
[14]. Although it was previously believed that declines in
hemoglobin levels might be a normal consequence of
aging, evidence has accumulated that anemia does re-
flect poor health and increased vulnerability to adverse
outcomes in older persons.
The result of this study shows that 13.8% of the popu-
lation with diabetes have clinically significant chronic
kidney disease (CKD), as defined by an eGFR <60 and
60–89 ml/min/1.73 m2, respectively. This finding is in
agreement with a study in USA which says 15.9% ofparticipants had at least moderately reduced kidney
function [15].
The prevalence of albuminuria in this study is 33.1%,
of these 14.1% had moderate renal failure and 10.7% had
mild renal failure. Sixty five percent of DM patients who
have a normal albumin level in their urine had a normal
renal function. This result is in agreement with a study
in Israel which shows prevalence of elevated albuminuria
(micro or macroalbuminuria) was 38.1%. 8.1% of pa-
tients had moderate and 31.4% had mild renal impair-
ment [14].
The study results showed that there is a significant as-
sociation between anaemia and renal function. Diabetes
mellitus patients with a mild renal failure have 4 times
greater (AOR = 4.29, 95% CI = 1.14, 16.13) risk to be
anemic than DM patients with a normal renal function.
As the glomerular filtration rate increase, the risk to be
anemic will decrease dramatically. Diabetes mellitus pa-
tients with a moderate renal failure have 11 times
greater (AOR = 11.13, 95% CI = 2.69, 45.94) risk to be
anemic than a normal renal function. This finding is in
agreement with a study in UK, which indicates from
anemic patients 36% with moderate renal failure and 9%
of those with mild renal failure [10].
In this study, the relation between HGB and eGFR
became negatively linear, as the estimated glomerular
filtration rate decreases, the level of haemoglobin
increases. The result of this study is in line with a retro-
spective study in UK, the prevalence of anemia increased
progressively with worsening CKD. People with CKD
stage 3 accounted for the largest number of people with
anemia; 18% (95% CI13–24) had HGB < 110 g/l. Most
patients with diabetes and anaemia can be identified
by examining patients with moderate to severe renal
Table 4 Bivariate logistic regression of selected variables
in relation to anemia among diabetes mellitus patients
attending fenote Selam Hospital, West Gojam, Northwest
Ethiopia, 2012
Anemia
Variables Yes No AOR (95% CI) P- value
Age groups
7-30 9 115 1*
31-45 9 94 1.22 (0.47, 3.21) < 0.682
46-60 35 78 5.73(2.61, 12.59)** < 0.001
>60 20 24 10.65(4.32, 26.23)** < 0.001
Place of residence
Urban 49 169 1*
Rural 24 142 0.58 (0.34, 0.99)** < 0.049
Educational status
Illiterates 32 91 1*
Able to read & write 14 27 1.47 (0.68, 3.16) < 0.317
Primary educ. (1–8) 18 105 0.48 (0.26, 0.93)** < 0.028
Secondary (9–10) 4 31 0.33 (0.11, 0.98)** < 0.047
Preparatory(11–12) 3 29 0.29 (0.08,1.03) < 0.056
College and above 2 24 0.24 (0.53, 1.06) < 0.060
Marital status
Single 9 85 1*
Married 27 199 1.28 (0.58, 2.84) < 0.541
Div. & Wid. 37 27 12.94 (5.54, 30.20)** < 0.001
Occupation
Students 7 41 1*
Farmers 21 117 1.05 (0.42, 2.65) < 0.916
G. Employee 15 51 1.72 (0.64, 4.62) < 0.280
Merchants 10 24 2.44 (0.82, 7.25) < 0.108
Housewife 4 27 0.86 (0.23, 3.25) < 0.833
Others 16 51 1.84 (0.34, 4.89) < 0.223
Type of diabetes
mellitus
Type 1 16 177 1*
Type 2 57 134 4.71 (2.58, 8.56)** < 0.001
Duration with diabetes
mellitus
<5 yrs 7 199 1*
6-10 30 94 9.07 (3.85, 21.41)** < 0.001
>11 36 18 16.86(22.12,145.91)** < 0.001
FBS
<126 7 98 1*
>126 66 213 4.34 (1.92, 9.80)** < 0.001
MCV
Normal 13 201 1*
Decreased 60 50 14.09 (12.31, 47.16)** < 0.001
Urine albumin
Table 4 Bivariate logistic regression of selected variables
in relation to anemia among diabetes mellitus patients
attending fenote Selam Hospital, West Gojam, Northwest
Ethiopia, 2012 (Continued)
Normal 3 254 1*
Increased 70 57 19.93(18.61, 85.72)** < 0.001
Serum creatinine
Normal 7 271 1*
Increased 66 40 11.06 (15.98, 60.36)** < 0.001
Serum BUN
Normal 5 271 1*
Increased 68 40 11.95 (11.68, 41.27)** < 0.001
GFR
< 60 51 6 14.38 (18.23, 89.48)** < 0.001
60-90 20 25 8.58 (10.21, 49.94)** < 0.001
>90 2 280 1*
*Reference category, ** significant association.
Table 5 Multi-variate logistic regression of selected
variables in relation to anemia among diabetes mellitus
patients attending Fenote Selam Hospital, 2012
Anemia




Type 1 16 177 1*




<5 yrs 7 199 1*
6-10 30 94 4.38 (1.22,15.75)**
>11 36 18 16.05 (3.92, 65.72)** <0.001
MCV <0.001
Normal 13 201 1*
Decreased 60 50 10.47(3.51, 31.24)**
eGFR <0.001
<60 51 6 11.13(2.69, 45.94)**
60-90 20 25 4.29 (1.14, 16.13)** <0.031
>90 2 280 1*
Serum creatinine <0.001
Normal 7 271 1*
Increased 66 40 8.55 (2.55, 28.62)**
Marital status <0.021
Single 9 85 1*
Married 27 199 0.116 (0.019, 0.719)**
Div. & Wido. 37 27 0.688 (0.109, 4.352) <0.691
*Reference category, ** significant association.
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ure and anaemia in diabetes probably reflect the unique
vulnerability of the renal microcirculation to damage in
diabetes [16].
Renal function as measured by eGFR was the strongest
predictor of anemia. Additional factors present in dia-
betes mellitus patients may contribute to the deve-
lopment of increased risk for anemia in patients with
diabetes. These factors are: Age of patients, Type of DM,
and duration with DM. The strengthen of this study is
that it is one of few studies in developing countries
where chronic disease like DM becoming more common
but the study is not without limitations and the limita-
tions of this study are lacks control groups, one time
GFR is measured only one time which may not tell us
the details of renal problem, as well proteinuria is mea-
sured only once this may be affected by different factors
at that spot rather than being pathological condition and
small sample size used for the study and which is not
able to generalize to the whole population of Ethiopia
and inclusion of young age of Participants may also
affect the result.
Conclusion
This study showed that anemia is public health problem
in the DM patients in the study area. As well this study
showed that there is a significant association between
anaemia and renal function. The prevalence of anaemia
increases as kidney function declines. Patients at greatest
risk can be identified by the presence of renal disease i.e.
by measuring their level of estimated glomerular filtra-
tion rate (eGFR). Therefore, DM patients should be
strictly monitored for renal failure and anemia for proper
management of diabetes patients as well physicians giving
care for DM patients should investigate the presence of
anemia and renal failure and treat as a routine work.
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